Johnson Midwest Financial’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Johnson Midwest Financial’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200	Closed	-$1K	–	331
2022 Q1	$1K	Hold	200	–	–	﹤0.01%	274
2021 Q4	$1K	Hold	200	–	–	﹤0.01%	295
2021 Q3	$1K	Hold	200	–	–	﹤0.01%	310
2021 Q2	$1K	Buy	+200	New	+$1.41K	﹤0.01%	289

Johnson Midwest Financial's CMPI Position: Q2 2022 in Review

Johnson Midwest Financial sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 200 shares — an estimated $1K sold.

Johnson Midwest Financial first reported a position in CMPI in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

Johnson Midwest Financial reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Johnson Midwest Financial sold 200 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1K.
Johnson Midwest Financial first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Johnson Midwest Financial's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $1K in Q1 2022.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Johnson Midwest Financial's 13F filing for Q2 2022, filed 18 Jul 2022.